GGrantIndex
Sort

166,118 grants matching stem cells

CH in Aging and Exceptional Longevity

$1,064,072
Aditi Shastri · Albert Einstein College Of Medicine · R01 · FY2025 · AG

Center for Targeted Therapeutics 2

$1,063,913
Hippokratis Kiaris · University Of South Carolina At Columbia · P20 · FY2023 · GM

Signaling in the retina and retinal pigment epithelium

$1,063,764
Thomas Redmond · National Eye Institute · ZIA · FY2013 · EY

Epigenetic Regulation of T cell differentiation

$1,063,685
Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

CDI-Type II: Extracting Population and Stochastic Effects on Signaling Activity from Transcription Factor Profiles

$1,063,684
Arul Jayaraman · Texas A&M Engineering Experiment Station · · FY2009 · ENG

Epigenetic Regulation of Embryonic and Hematopoietic Stem Cells

$1,063,684
Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

The Enhancer Code of AD-A Genetic Approach

$1,063,676
Christopher K Glass · University Of California, San Diego · R01 · FY2022 · AG

Interventional approaches for restoring vision

$1,063,252
Anand Swaroop · National Eye Institute · ZIA · FY2017 · EY

Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model

$1,063,173
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL

Spatiotemporal epigenomic and chromosomal architectural cell atlas of developing human brains

$1,063,112
Chongyuan Luo · University Of California Los Angeles · U01 · FY2022 · MH

The Enhancer Code of AD-A Genetic Approach

$1,063,091
Christopher K Glass · University Of California, San Diego · R01 · FY2021 · AG

Sorafenib for Hepatopulmonary Syndrome

$1,062,899
Steven M Kawut · University Of Pennsylvania · UM1 · FY2013 · HL

Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation

$1,062,441
Robert J Coffey · Vanderbilt University Medical Center · R35 · FY2024 · CA

University of Pennsylvania Patient-derived Xenograft Development and Trials Center

$1,062,215
Martin Carroll · University Of Pennsylvania · U54 · FY2025 · CA

STEM CELL BIOLOGY: NEW DIRECTIONS IN CLINICAL AND BASIC RESEARCH

$1,062,112
Peter J Quesenberry · Rhode Island Hospital · P20 · FY2010 · RR

The TGFβ Signaling Pathway in Development and Cancer

$1,062,000
Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA

The TGFβ Signaling Pathway in Development and Cancer

$1,062,000
Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA

Novel therapeutic development for small cell lung cancer

$1,062,000
Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA

The TGF Beta Signaling Pathway in Development and Cancer

$1,062,000
Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA

Novel therapeutic development for small cell lung cancer

$1,062,000
Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA

Transgenic Core Facility

$1,061,979
Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

GENE THERAPY FOR METABOLIC DISORDERS

$1,061,927
University Of Minnesota Twin Cities · P01 · FY2001 · HD

Massively-parallel functional interrogation of psychiatric genetics

$1,061,900
Feng Zhang · Broad Institute, Inc. · R01 · FY2016 · MH

Stem Cells And The Origins of Barrett's Esophagus

$1,061,716
Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2013 · CA

ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias

$1,061,682
Craig Blackstone · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS